Reduced immunogenicity with a new formulation of interferon-beta-1a (Rebif (R)): 24-week results of a phase IIIb study
暂无分享,去创建一个
P. Sørensen | G. Giovannoni | B. Stubinski | G. Pardo | O. Barbarash | L. Metz | J. King | L. Mitchell | A. Jaber | J. Simsarian